{"id":"https://openalex.org/W2011751244","doi":"https://doi.org/10.1358/dot.2007.43.11.1157620","title":"Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update)","display_name":"Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update)","alternate_titles":[],"publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2011751244","doi":"https://doi.org/10.1358/dot.2007.43.11.1157620","mag":"2011751244","pmid":"https://pubmed.ncbi.nlm.nih.gov/18174966"},"language":"en","primary_location":{"id":"doi:10.1358/dot.2007.43.11.1157620","doi":"https://doi.org/10.1358/dot.2007.43.11.1157620","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dot.2007.43.11.1157620","pdf_url":null,"source":{"id":"https://openalex.org/S202615048","display_name":"Drugs of today","issn_l":"0025-7656","issn":["0025-7656","1699-3993","1699-4019"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4360969288","host_organization_name":"Prous Science","host_organization_lineage":["https://openalex.org/P4360969288"],"host_organization_lineage_names":["Prous Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of Today","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011751244"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105783630","display_name":"Baptist Gallwitz","orcid":"https://orcid.org/0000-0002-8880-6409","observed_orcids":["https://orcid.org/0000-0002-8880-6409"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gallwitz, B.","raw_affiliation_strings":["Department of Medicine IV, Eberhard-Karls-University, Tubingen, Germany. baptist.gallwitz@med.uni-tuebingen.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine IV, Eberhard-Karls-University, Tubingen, Germany. baptist.gallwitz@med.uni-tuebingen.de","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105783630"],"corresponding_institution_ids":["https://openalex.org/I8087733"],"apc_list":null,"apc_paid":null,"fwci":4.2169,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.94249434,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"43","issue":"11","first_page":"801","last_page":"801"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.7419999837875366},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.875},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.8980000019073486},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9409999847412109},{"id":"https://openalex.org/keywords/glucagon-secretion","display_name":"glucagon secretion","score":0.8970000147819519},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.9179999828338623},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8349999785423279},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.9580851793289185},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8462611436843872},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7930420637130737},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6715502738952637},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6535766124725342},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.6270100474357605},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6112183332443237},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5425233840942383},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5103792548179626},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4988696575164795},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.43913984298706055},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4083154797554016},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4038007855415344}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1358/dot.2007.43.11.1157620","doi":"https://doi.org/10.1358/dot.2007.43.11.1157620","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dot.2007.43.11.1157620","pdf_url":null,"source":{"id":"https://openalex.org/S202615048","display_name":"Drugs of today","issn_l":"0025-7656","issn":["0025-7656","1699-3993","1699-4019"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4360969288","host_organization_name":"Prous Science","host_organization_lineage":["https://openalex.org/P4360969288"],"host_organization_lineage_names":["Prous Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of Today","raw_type":"journal-article"},{"id":"pmid:18174966","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18174966","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of today (Barcelona, Spain : 1998)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W24397505","https://openalex.org/W1598254642","https://openalex.org/W1731612336","https://openalex.org/W1964607604","https://openalex.org/W1965136952","https://openalex.org/W1968926450","https://openalex.org/W1969932276","https://openalex.org/W1979916078","https://openalex.org/W1985047837","https://openalex.org/W1987182389","https://openalex.org/W1991306787","https://openalex.org/W1994743271","https://openalex.org/W1999206977","https://openalex.org/W2013082477","https://openalex.org/W2027547437","https://openalex.org/W2031468509","https://openalex.org/W2032322539","https://openalex.org/W2036939737","https://openalex.org/W2050644450","https://openalex.org/W2051462052","https://openalex.org/W2054185381","https://openalex.org/W2054564814","https://openalex.org/W2061202826","https://openalex.org/W2068183831","https://openalex.org/W2075404533","https://openalex.org/W2079644358","https://openalex.org/W2080677146","https://openalex.org/W2083473802","https://openalex.org/W2085862152","https://openalex.org/W2087707716","https://openalex.org/W2089109393","https://openalex.org/W2089304685","https://openalex.org/W2091942573","https://openalex.org/W2104763836","https://openalex.org/W2106558322","https://openalex.org/W2118609667","https://openalex.org/W2123629330","https://openalex.org/W2130083450","https://openalex.org/W2135349217","https://openalex.org/W2136752386","https://openalex.org/W2141264129","https://openalex.org/W2141390547","https://openalex.org/W2143014102","https://openalex.org/W2154615287","https://openalex.org/W2171512247","https://openalex.org/W2397691160","https://openalex.org/W4234825176"],"related_works":["https://openalex.org/W4231761993","https://openalex.org/W4298264018","https://openalex.org/W4284881278","https://openalex.org/W7099615316","https://openalex.org/W2109211688","https://openalex.org/W1981985904","https://openalex.org/W2020543244","https://openalex.org/W2080866420","https://openalex.org/W1988126703","https://openalex.org/W2065582045"],"abstract_inverted_index":{"Novel":[0],"therapeutic":[1,52],"strategies":[2],"for":[3],"type":[4,39],"2":[5,40],"diabetes":[6],"are":[7,62],"needed,":[8],"since":[9],"the":[10,21,36,70,83,122,186],"current":[11],"treatment":[12],"options":[13],"neither":[14],"address":[15],"all":[16],"pathophysiological":[17],"mechanisms":[18,187],"nor":[19],"achieve":[20],"glycemic":[22],"target":[23],"goals.":[24],"A":[25],"general":[26],"islet-cell":[27],"dysfunction":[28],"including":[29],"insulin-":[30],"and":[31,57,87,104,111,125,138,147,191],"glucagon-secretion":[32],"defects":[33],"contributes":[34],"to":[35,67,108,176],"pathophysiology":[37],"of":[38,69,72,85,93,144,149,162,172,185,188,195],"diabetes.":[41],"Improving":[42],"islet":[43],"function":[44],"by":[45,141],"incretin":[46,64],"hormone":[47],"action":[48],"is":[49,101,153],"a":[50,76,98,159,169],"novel":[51],"approach.":[53],"Glucagon-like":[54],"peptide-1":[55],"(GLP-1)":[56],"glucose-dependent":[58,142],"insulinotropic":[59],"peptide":[60],"(GIP)":[61],"important":[63],"hormones":[65],"contributing":[66],"50-70%":[68],"stimulation":[71,143],"insulin":[73,145],"secretion":[74,146],"after":[75],"meal.":[77],"Dipeptidyl-peptidase":[78],"IV":[79],"(DPP-4)":[80],"inhibitors":[81],"inhibit":[82],"degradation":[84],"GLP-1":[86],"GIP":[88],"as":[89,91],"well":[90],"that":[92],"other":[94,126,129],"regulatory":[95],"peptides.":[96],"Sitagliptin,":[97],"DPP-4":[99,130],"inhibitor,":[100],"orally":[102],"active":[103],"has":[105,117],"been":[106],"shown":[107],"be":[109],"efficacious":[110],"safe":[112],"in":[113,120,174],"clinical":[114,192],"studies.":[115],"Sitagliptin":[116,152,165],"received":[118],"approval":[119],"Mexico,":[121],"United":[123],"States":[124],"countries.":[127],"Like":[128],"inhibitors,":[131],"sitagliptin":[132],"reduces":[133],"hemoglobin":[134],"A1c":[135],"(HbA1c),":[136],"fasting":[137],"postprandial":[139],"glucose":[140],"inhibition":[148],"glucagon":[150],"secretion.":[151],"weight":[154],"neutral.":[155],"Indirect":[156],"measures":[157],"show":[158],"possible":[160],"improvement":[161],"beta-cell":[163],"function.":[164],"does":[166],"not":[167],"cause":[168],"higher":[170],"rate":[171],"hypoglycemia":[173],"comparison":[175],"metformin":[177],"or":[178],"placebo.":[179],"This":[180],"article":[181],"gives":[182],"an":[183],"overview":[184],"action,":[189],"pharmacology":[190],"trial":[193],"results":[194],"sitagliptin.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011751244","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
